CSGlcA-T Polyclonal Antibody

Rabbit Anti-CSGlcA-T Polyclonal Antibody

Product Specifications

Background

CHPF2 (Chondroitin Polymerizing Factor 2) is a Protein Coding gene. Among its related pathways are Defective B3GAT3 causes JDSSDHD and Metabolism. GO annotations related to this gene include transferase activity, transferring glycosyl groups and N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity. An important paralog of this gene is B4GALNT4.

CAS Number

9007-83-4

Product Name Alternative

CHPF2; CHSY3; CSGLCAT; KIAA1402; Chondroitin sulfate glucuronyltransferase; CSGlcA-T; Chondroitin glucuronyltransferase; Chondroitin polymerizing factor 2; ChPF-2; Chondroitin synthase 3; ChSy-3; N-acetylgalactosaminyl-proteoglycan 3-beta-g

Gene ID

54480

Accession Number

Q9P2E5

Reactivity

Human

Immunogen

Synthesized peptide derived from the N-terminal region of human CSGlcA-T at AA range: 1-80

Clonality

Polyclonal

Tag

Chondroitin sulfate glucuronyltransferase

Applications

WB, IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

86kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

CSGlcA-T Polyclonal Antibody detects endogenous levels of CSGlcA-T protein.

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000; IHC 1:100-1:300; ELISA 1:40000; IF 1:50-200